STOCK TITAN
  1. Home
  2. Sec-filings
  3. KINS
  4. [Form 4] Kingstone Companies, Inc. Insider Trading Activity

[Form 4] Kingstone Companies, Inc. Insider Trading Activity

Minlei Chen, Chief Actuary and Senior VP of Kingstone Companies (KINS), reported significant equity transactions on June 18, 2025.

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Minlei Chen, Chief Actuary and Senior VP of Kingstone Companies (KINS), reported significant equity transactions on June 18, 2025. The insider received 10,000 shares of common stock through a restricted stock grant at $0 per share, bringing their total beneficial ownership to 29,340 shares.

The filing details vesting schedules for restricted stock grants:

  • 3,645 shares vest on March 3, 2026
  • 3,333 shares vest on June 18, 2026
  • 3,645 shares vest on March 3, 2027
  • 3,333 shares vest on June 18, 2027

Additionally, Chen holds stock options for 10,000 shares at an exercise price of $2.25, vesting in three tranches: 3,334 shares on January 5, 2025, and 3,333 shares each on January 5, 2026, and 2027. This compensation structure aligns with long-term retention and performance incentives.

Positive

  • Chief Actuary and Senior VP received 10,000 shares of restricted stock grant, demonstrating long-term alignment with shareholder interests through 4-year vesting schedule

Negative

  • None.
Insider Chen Minlei
Role Chief Actuary and Senior VP
Type Security Shares Price Value
Grant/Award Common Stock 10,000 $0.00 $0.00
holding Stock Option -- -- --
Holdings After Transaction: Common Stock — 29,340 shares (Direct); Stock Option — 10,000 contracts (Direct)
Footnotes (3)
  1. F1. Shares received pursuant to restricted stock grant.
  2. F2. Includes 13,956 shares received pursuant to unvested restricted stock grant. Such shares vest to the extent of 3,645 shares on March 3, 2026, 3,333 shares on June 18, 2026, 3,645 shares on March 3, 2027 and 3,333 shares on June 18, 2027.
  3. F3. The option vests and becomes exercisable to the extent of 3,334 shares on January 5, 2025 and 3,333 shares on each of January 5, 2026 and January 5, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares of KINS stock did Chief Actuary Minlei Chen receive on June 18, 2025?
According to the Form 4 filing, Minlei Chen received 10,000 shares of KINS common stock on June 18, 2025 through a restricted stock grant at $0 cost basis.

What is the vesting schedule for KINS Chief Actuary's restricted stock grant?
The restricted stock grant of 13,956 shares vests in four tranches: 3,645 shares on March 3, 2026, 3,333 shares on June 18, 2026, 3,645 shares on March 3, 2027, and 3,333 shares on June 18, 2027.

What stock options does Minlei Chen hold in KINS and what is their exercise price?
Minlei Chen holds 10,000 stock options with an exercise price of $2.25 per share. These options expire on January 5, 2029 and vest in three tranches: 3,334 shares on January 5, 2025, and 3,333 shares each on January 5, 2026 and January 5, 2027.

How many total shares of KINS does Minlei Chen beneficially own after the June 18, 2025 transaction?
Following the reported transaction, Minlei Chen beneficially owns 29,340 shares of KINS common stock directly, which includes 13,956 shares from unvested restricted stock grants.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chen Minlei
(Last) (First) (Middle)
C/O KINGSTONE COMPANIES, INC.
120 WOOD ROAD
(Street)
KINGSTON NY 12401
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
KINGSTONE COMPANIES, INC. [ KINS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Actuary and Senior VP
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/18/2025 A 10,000 A $0(1) 29,340(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $2.25 (3) 01/05/2029 Common Stock 10,000 10,000 D
Explanation of Responses:
1. Shares received pursuant to restricted stock grant.
2. Includes 13,956 shares received pursuant to unvested restricted stock grant. Such shares vest to the extent of 3,645 shares on March 3, 2026, 3,333 shares on June 18, 2026, 3,645 shares on March 3, 2027 and 3,333 shares on June 18, 2027.
3. The option vests and becomes exercisable to the extent of 3,334 shares on January 5, 2025 and 3,333 shares on each of January 5, 2026 and January 5, 2027.
/s/ Minlei Chen 06/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

Keep reading

More on KINS

Trending in the feed

Open the live feed